Treatment Intensification following Glucagon-Like Peptide-1 Receptor Agonist Treatment in Type 2 Diabetes: the RESTORE-G Real-World Study

To assess intensification approaches with basal insulin (BI) following glucagon-like peptide-1 receptor agonist (GLP1-RA) treatment in type 2 diabetes (T2D).

Source: Nutrition, Metabolism, and Cardiovascular Diseases : NMCD - July 21, 2023 Category: Nutrition Authors: Riccardo Candido, Antonio Nicolucci, Monica Larosa, Maria Chiara Rossi, Raffaele Napoli, RESTORE-G (Retrospective analysis on the therapeutic approaches after GLP1-RA treatment in type 2 diabetes patients) Study Group Source Type: research